Dedicated Diagnostic Radiology/Radiation Oncology Rounds: Added Value Beyond Traditional Tumor Boards.

Journal Article (Journal Article)

OBJECTIVES: We aimed to evaluate the impact of collaborative discussion between diagnostic radiologists and radiation oncologists on radiation oncology management for thoracic oncology patients. METHODS: We reviewed cases presented at multidisciplinary thoracic tumor boards (TTB) (n = 122) and diagnostic radiology/radiation oncology rounds (DR/ROR) (n = 45). Changes in planned radiation management following imaging discussion were categorized-no change, timing change, and treatment volume change. Phase of care was also classified. In DR/ROR, radiation oncologists were surveyed regarding (1) change in radiation oncology management and (2) change in confidence (both 5-point Likert scales). RESULTS: Discussion of imaging with a radiologist changed radiation oncology management in 31.1% of TTB cases and 68.9% of DR/ROR cases (P < 0.001). Changes to the timing of initiating radiation therapy occurred with similar frequency in the 2 settings (31.1% vs 46.7%, P = 0.063). Changes to target volume occurred more frequently in DR/ROR (35.6% vs <1%), P < 0.001. Over half of imaging discussions in DR/ROR resulted in at least "moderate" change in radiation oncology management, and the level of confidence held by the radiation oncologists increased following discussion with radiologists in 95.6% of cases. CONCLUSION: Collaborative discussions between radiation oncologists and diagnostic radiologists in a multispecialty tumor board and in targeted 2-specialty rounds are not redundant, but result in different management changes and at different phases of care. Our study emphasizes the importance of consultation with physicians as an area where radiologists can add value, specifically the added benefit of smaller collaborative discussions.

Full Text

Duke Authors

Cited Authors

  • Kallianos, KG; Muhoozi, BN; Gottschalk, A; Yom, SS; Chan, JW; Henry, TS; Elicker, BM; Ordovas, KG; Naeger, DM

Published Date

  • 2020

Published In

Volume / Issue

  • 49 / 4

Start / End Page

  • 248 - 253

PubMed ID

  • 31153661

Electronic International Standard Serial Number (EISSN)

  • 1535-6302

Digital Object Identifier (DOI)

  • 10.1067/j.cpradiol.2019.05.004


  • eng

Conference Location

  • United States